This page lists the SEC filings reported by New Enterprise Associates 14, L.P..
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2020-12-10 | New Enterprise Associates 14, L.P. | Mersana Therapeutics, Inc. | - | - | EDGAR |
SC 13D/A | 2020-11-19 | New Enterprise Associates 14, L.P. | Mersana Therapeutics, Inc. | 3,959,520 | 5.8% | EDGAR |
SC 13D/A | 2020-09-22 | New Enterprise Associates 14, L.P. | Mersana Therapeutics, Inc. | 5,959,520 | 8.7% | EDGAR |
SC 13D/A | 2020-04-24 | New Enterprise Associates 14, L.P. | Mersana Therapeutics, Inc. | 7,959,520 | 12.8% | EDGAR |
SC 13D | 2020-04-01 | New Enterprise Associates 14, L.P. | LUMOS PHARMA, INC. | 524,030 | 6.3% | EDGAR |
SC 13D | 2020-03-20 | New Enterprise Associates 14, L.P. | IMARA Inc. | 4,013,995 | 24.2% | EDGAR |
SC 13D | 2020-02-20 | New Enterprise Associates 14, L.P. | Casper Sleep Inc. | 6,222,412 | 15.7% | EDGAR |
SC 13G/A | 2020-02-13 | New Enterprise Associates 14, L.P. | Elastic N.V. | - | - | EDGAR |
SC 13G/A | 2020-02-13 | New Enterprise Associates 14, L.P. | MongoDB, Inc. | - | - | EDGAR |
SC 13G/A | 2020-02-13 | New Enterprise Associates 14, L.P. | Surface Oncology, Inc. | 3,312,877 | 11.9% | EDGAR |
SC 13G | 2020-02-13 | New Enterprise Associates 14, L.P. | Galera Therapeutics, Inc. | 4,358,042 | 17.6% | EDGAR |
SC 13D | 2019-11-08 | New Enterprise Associates 14, L.P. | Oyster Point Pharma, Inc. | 5,925,287 | 28.7% | EDGAR |
SC 13D/A | 2019-03-14 | New Enterprise Associates 14, L.P. | Mersana Therapeutics, Inc. | 11,890,138 | 24.9% | EDGAR |
SC 13G | 2019-02-13 | New Enterprise Associates 14, L.P. | Surface Oncology, Inc. | 3,312,877 | 12.0% | EDGAR |
SC 13G | 2019-02-13 | New Enterprise Associates 14, L.P. | Elastic N.V. | 6,353,498 | 9.0% | EDGAR |
SC 13G/A | 2019-02-12 | New Enterprise Associates 14, L.P. | APPIAN CORP | - | - | EDGAR |
SC 13D | 2018-09-17 | New Enterprise Associates 14, L.P. | Adaptimmune Therapeutics PLC | 94,978,668 | 15.2% | EDGAR |
SC 13D/A | 2018-05-14 | New Enterprise Associates 14, L.P. | MULESOFT, INC | - | - | EDGAR |
SC 13D/A | 2018-04-03 | New Enterprise Associates 14, L.P. | Tracon Pharmaceuticals, Inc. | 3,568,753 | 20.0% | EDGAR |
SC 13D | 2018-03-29 | New Enterprise Associates 14, L.P. | MULESOFT, INC | 16,115,887 | 15.3% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.